CLINICAL_TRIALS
trial_result
· 2023-06-27
Clinical Trial Update: Telotristat With Lutathera in Neuroendocrine Tumors [Phase 2]
Summary
Phase 2 trial investigating telotristat with Lutathera in neuroendocrine tumors was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lowell Anthony, MD | Conditions: Neuroendocrine Tumors | Phase 2 | Status: TERMINATED | Results posted: 2023-06-27